Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar Fishboy1970 (< 20) Submitted: 6/21/2012 6:48:47 AM : Underperform Start Price: $10.75 ARNA Score: +2.29

Will get delayed FDA!!

Featured Broker Partners


Advertisement